Gunawardana, Manjula
Remedios-Chan, Mariana
Sanchez, Debbie
Webster, Simon
Castonguay, Amalia E.
Webster, Paul
Buser, Christopher
Moss, John A.
Trinh, MyMy
Beliveau, Martin
Hendrix, Craig W.
Marzinke, Mark A.
Tuck, Michael
Caprioli, Richard M.
Reyzer, Michelle L.
Kuo, Joseph
Gallay, Philippe A.
Baum, Marc M.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01AI120748)
Article History
Received: 18 October 2021
Accepted: 15 April 2022
First Online: 17 May 2022
Competing interests
: Authors MyMy Trinh and Martin Beliveau were employed by the company Certara Integrated Drug Development. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.